A carregar...
Virtual screening and experimental validation of novel histone deacetylase inhibitors
BACKGROUND: Histone deacetylases (HDACs) are promising therapeutic targets for the treatment of cancer, diabetes and other human diseases. HDAC inhibitors, as a new class of potential therapeutic agents, have attracted a great deal of interest for both research and clinical applications. Increasing...
Na minha lista:
| Publicado no: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955146/ https://ncbi.nlm.nih.gov/pubmed/27443303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-016-0075-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|